Target intelligence / Profile preview

Folliculin-interacting protein 2 (FNIP2)

Target
FNIP2
Molecular classification
Other (adaptor protein, scaffold protein), Co-chaperone, Tumor suppressor complex component
01

Overview

Folliculin-interacting protein 2 (FNIP2) is a protein encoded by the FNIP2 gene, which acts as a binding partner for the tumor suppressor folliculin (FLCN) and AMP-activated protein kinase (AMPK). FNIP2 is a component of signaling pathways regulating cellular metabolism, nutrient sensing, and mTORC1 activity, particularly under conditions of varying amino acid availability. It helps promote FLCN recruitment to lysosomes and regulates the MiT/TFE family of transcription factors by modulating the mTORC1 pathway. FNIP2, together with FLCN, regulates autophagy and is involved in apoptosis in response to DNA damage by O6-methylguanine. FNIP2 also acts as a co-chaperone for Hsp90, modulating its ATPase activity and facilitating the chaperoning and stabilization of client proteins. Genetic studies link FNIP2 to obesity and leanness phenotypes, where certain variants in its 3’UTR affect mRNA stability and human body composition. FNIP2 plays a critical role in kidney tumor suppression in cooperation with FLCN and FNIP1, and disruption of its function is implicated in kidney cancer and Birt-Hogg-Dubé syndrome.

Other names
Folliculin-interacting protein 2FNIP2FNIPLKIAA1450MAPO1FNIP1-like proteinO6-methylguanine-induced apoptosis 1 proteinO6-methylguanine-induced apoptosis 1
02

Biological functions

Regulation of cellular metabolismNutrient sensingRegulation of mTORC1 signaling pathwayRegulation of AMPK (AMP-activated protein kinase)Regulation of autophagyApoptosis (specifically O6-methylguanine-induced apoptosis signaling)Negative regulation of Hsp90 ATPase activity
03

Disease associations

Cancer (kidney cancer, tumor suppression)Birt-Hogg-Dubé syndromeFamilial renal oncocytomaObesity and metabolic disorders
04

Biomarkers

Expression levels of FNIP2 as a biomarker for leanness or obesity-related phenotypesPotential as a marker for kidney tumor suppression

Beyond the preview

Go deeper on Folliculin-interacting protein 2 (FNIP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folliculin-interacting protein 2 (FNIP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call